Back to Trials
NCT06397469NARecruitingAccepts Healthy Volunteers

Enhancing Attention and Wellbeing Using Digital Therapeutics

University of California, San Francisco

Start Date

4/1/2024

Completion Date

6/1/2029

Summary

The goals of the proposed research are to first determine the minimal and/or optimal dose of a digital intervention required for cognitive enhancement, and then to examine the impact of several potential moderators of treatment effects (i.e., cognitive decline, AD polygenic hazard score, cardiovascular risk, and race/ethnicity). This knowledge gained from his high-impact study with transform the field of cognitive interventions, paving the way for a precision medicine model for cognitive enhancing interventions that improve quality of life for older adults and individuals with cognitive deficits at risk of developing dementia.

Eligibility Criteria

Age Range: 60 years to 99 years

Inclusion Criteria: * 60+ years old (adult) * English language fluency * owning a smartphone or tablet Exclusion Criteria: * Under 60 years old (minor)

Interventions

DEVICE

MediTrain

DEVICE

Worder

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

AgingMCICognitive Decline

Locations

University of California San Francisco

San Francisco, California 94158

United States